Enanta Pharmaceuticals Investor Relations Material
Latest events
Study Result
Enanta Pharmaceuticals
Corporate Presentation
5 Jun, 2025
Q2 2025
12 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Enanta Pharmaceuticals Inc
Access all reports
Enanta Pharmaceuticals Inc is a biotechnology company focused on the research and development of small molecule drugs targeting viral infections and liver diseases. It specializes in therapies for hepatitis, respiratory infections, and other viral illnesses. The company is headquartered in Watertown, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Enanta Pharmaceuticals Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Enanta Pharmaceuticals Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Enanta Pharmaceuticals Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ENTA
Country
🇺🇸 United States